Direct answer:Labeler Code, NDC and Drug Listing are different things that connect. Before the initial listing or retention of the NDC, a check should be made as to whether the applicable code is available; The FDA assigns Labeler Code with a code confirmation record. Specific medicines and packagings are recoded in accordance with the rules, submitted for listing and maintained; Obtaining a NDC or catalogue does not represent an FDA approval.
I. How does Labeler Code, the product code and the packing code distinguish?
NDC consists of three levels: labeler, product and packaging. Labeler Code Identification Associates; Product and packaging levels should be checked against specific pharmaceutical characteristics and packaging configurations. The entire product cannot be considered to have been listed by simply obtaining the company code, nor can it randomly reproduce the unconnected enterprise code.
The registration of facilities identifies actual drug sites and activities; See you in detail about the division of labour.Registration and information maintenance of pharmaceutical businesses。
II. Which enterprises need to apply for Labeler Code?
Manufacturing, distribution, brand labels and surrogate relationships should be checked first. FDA usually requires applications from relevant pharmaceutical manufacturers and distributors; Companies that do not manufacture or distribute medicines in the United States should not simply obtain a number application. Where codes are available, the subject matter and purpose are identified and duplication of requests is avoided.
The same manufacturer has multiple facilities and does not necessarily require separate application codes for each site. The responsibility for listing the owner-brand distributor and the actual manufacturer should be made clear in the context of their respective activities and applicable rules, and it should not be seen solely as to who owns the trademark.
III. Why is there a confirmation step for the code application?
Prepares the Saber Code request SPL according to the current FDA process, leaving the corresponding code bar empty at the time of the first request. An updated SPL with new code will also be submitted for confirmation after the FDA has been cleared and allocated; If this step is not completed, the following name cannot be used for this code.
Changes in information such as contact persons, business activities or types of drugs to be coded shall be updated within thirty days as required by the FDA. Company name change, M & As or code transfer should also check the product listing under the flag; Codes that have not been associated with listings for two years may be disabled.
IV. What product data is required for a specific listing?
- Listed categories and supporting grounds, product names, agent types and modes of delivery are applied.
- Name, UNII, content or strength of the active ingredient and appropriate unit; If necessary, check SPL strength conversion.
- Information applicable to non-active ingredients and their UNII.
- Data on products and packaging NDC, packing specifications, commercial distribution start-up, etc.
- The current full label text, overpack and the main display image.
- Name of relevant production facility, DUNS, physical activity and supply chain relationship.
These data should be consistent with real products and labels; API also seeAPI Drug Listing Guide。
How to arrange for the transmission, updating and no change of accreditation?
The applicable subject and code work is completed before the correct listing SPL type is selected, data are prepared, reviewed and submitted, and verification feedback processed. FDA’s first listing instructions require submission of an initial listing within three days of the first registration of the facility, and specific items should be checked against applicable legislation and subsequent new products.
Changes in information should be updated as soon as possible and no later than June or December, when applicable. (a) Whether the year should be updated on a record basis or whether the applicable no-change certification should be submitted between 1 October and 31 December; If change occurs, it cannot be certified directly without change. Save the pre-version SPL, version and acceptance results and review the public display.
How do we connect the current code to the future of the 12-bit NDC?
As of 2026-11-06, FDA is still in the 10-digit, three-part NDC format. The uniform 12-digit format rules will enter into force on 2033-03-07; The FDA indicates that the current format of ten NDC will continue to be allocated until it is effective. The new rules should not lead to the direct conversion of all existing declarations into twelve places.
Eleven formats for other purposes, such as reimbursement, cannot be confused with the current FDA logo. When it comes to the migration of future systems and labels, the data should be checked on a case-by-case basis against the printed version in accordance with the current transitional rules of the FDA.
VII. What are the boundaries, periodicity and cost of catalogue queries?
Is there a NDC that sells legally?Can't. The catalogue is derived from declared data and does not indicate that FDA has certified, approved or approved products as medicines, or represents eligibility for medical insurance reimbursement. Listing routes and compliance requirements need to be met separately.
Why can't the catalogue be found after the system's acceptance?The date of the marketing stop date, the authentication and listing status, the database checked and the range of entries in the catalogue should be reconciled, and the results of the inquiries should not be used to reverse either “approved” or “unlisted”.
How are the processing times and costs estimated?(a) Code requests, post-allocation confirmations, product packaging data, labels and listing verifications are scheduled separately; Service charges are quoted by subject, item, package and feedback range, and other applicable user fees are shown separately from third-party work.
Official sources and service portals
- FDA | Labeler Code Request, Confirmation and Update
- FDA | Drug Listing Data and Maintenance
- FDA | NDC Directory Scope and Search Borders
- FDA's current NDC and 2033 new format arrangements
View NDC Labeler Code, NDC Encoding and Drug Listing Services and Preparations
Submission of business and product summaries, terms of reference and quotations
Official data checks and updates: 2026-11-06. Author: Mr. Otsun; Audit: Mr. Toto. Specific requirements are based on products, business activities and current FDA applicable rules.
Continue reading and preparation
- FDA Unauthorized Drugs and NDC: Why not the listing record equals legal listing
- API Drug Listing: Who is responsible for submitting the information and whether the information on the customer of the formulation is necessary?
Further consolidation of project information is availableNDC Labeler Code Application, NDC Encoding and Drug Listing; The scope, processing cycles and costs are shown on the corresponding service page.